Dutch molecular diagnostics company Qiagen said Tuesday it would “dramatically” ramp up its production of the components needed for the RNA extraction kits used to detect the novel coronavirus in a patient sample.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,